The Food and Drug Administration has approved Helixate FS, Antihemophilic Factor for prophylaxis treatment for children 16 years old and younger. As always it is important to discuss any new or potentially new treatments with your doctor or your child’s doctor. The prophylaxis treatment is for children who have hemophilia A and who do not have any existing joint damage. For more information contact your doctor or go to the CSL Behring Web site or the Helixate FS Web site, www.HelixateFS.com .